News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gynecor™, a Division of Bostwick Laboratories, Adds New State-of-the-Art Lab Technology to Help Physicians Identify Patients at Risk for Cervical Cancer, Improve Treatment Decisions


9/26/2012 8:56:44 AM

ORLANDO, Fla.--(BUSINESS WIRE)--Gynecor, a division of Bostwick Laboratories, Inc. an anatomical pathology and molecular testing laboratory, has made an investment in advanced laboratory technology to help physicians know more about a patient’s condition and to help them identify which patients are at risk for certain diseases, such as cervical cancer, to help improve patient treatment decisions.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES